2013-04-29 15:32:01 -
MEMPHIS, TENN. - April 29, 2013- Medtronic, Inc. (NYSE: MDT) the world leader in
spinal technology announced today the U.S. launch of several new product line
additions to the VERTEX SELECT® Reconstruction System. The announcement was
made at the 81(st) American Association of Neurological Surgeons (AANS) Annual
Scientific Meeting in New Orleans.
This compliment to the VERTEX SELECT® Reconstruction System adds an additional
selection of various size implants including pre-cut/bent rods, tapered rods,
and other connecting implant options. The VERTEX SELECT® Reconstruction System
is used to treat DDD (neck pain of discogenic origin with degeneration of the
disc confirmed by history and radiographic studies), spondylolisthesis, spinal
stenosis, fracture, dislocation, failed previous fusion and/or tumors.
"We are excited to continue to expand surgeon's options when treating patients",
said Doug King, senior vice president
and president of Medtronic's Spinal
business. "When you combine the implant options available in the VERTEX SELECT®
Reconstruction System with the recently introduced CERVICAL FACETLIFT(SM)
Indirect Decompression and Stabilization surgical technique, Medtronic can now
offer surgeons a true innovative procedure to treat these patients," said King.
These new additions to the VERTEX SELECT® Reconstruction System will give
surgeons more treatment options for performing posterior cervical-upper thoracic
surgical procedures. Originally introduced in 2001, the VERTEX® System product
line has more than 12 years of clinical experience.
The CERVICAL FACETLIFT(SM) ID/S surgical technique incorporates technology
developed by Gary K. Michelson, M.D.
About the Spinal Business at Medtronic
The Spinal business, based in Memphis, Tenn., is the global leader in today's
spine market and is committed to advancing the treatment of spinal conditions.
The Spinal business collaborates with world-renowned surgeons, researchers and
innovative partners to offer state-of-the-art products and technologies for
neurological, orthopaedic and spinal conditions. Medtronic is committed to
developing affordable, minimally invasive procedures that provide lifestyle
friendly surgical therapies.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global
leader in medical technology - alleviating pain, restoring health, and extending
life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as
those described in Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from anticipated
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Medtronic, Inc. via Thomson Reuters ONE